MEDI4736 and Tremelimumab

Elodie_Espesset July 9, 2016, 9:26am 1

A new immunotherapy trial is coming to MD Anderson:

The targets are PD-L1 and CTLA-4.

Topic		Replies	Views
https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2015-1071.html Clinical Trials and Research Updates	1	2167	May 21, 2017
MK-3475 Immunotherapy Trial Blog	5	626	February 1, 2015
Immunotherapy for Sarcoma Clinical Trials and Research Updates	0	2409	December 7, 2016
Immunotherapy Personal Experience with Clinical Trials	5	2856	March 28, 2015
Neoadjuvant Durvalumab and Tremelimumab Plus Radiation Clinical Trials and Research Updates	0	2180	April 19, 2017